Aneusomy 17 in Breast Cancer: Its Role in HER-2/neu Protein Expression and Implication for Clinical Assessment of HER-2/neu Status
- 1 February 2002
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 15 (2) , 137-145
- https://doi.org/10.1038/modpathol.3880505
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- HER-2/neu Testing in Breast Carcinoma: A Combined Immunohistochemical and Fluorescence In Situ Hybridization ApproachLaboratory Investigation, 2000
- HER-2/neu Gene Amplification Compared With HER-2/neu Protein Overexpression and Interobserver Reproducibility in Invasive Breast CarcinomaAmerican Journal of Clinical Pathology, 2000
- Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assaysJournal of Clinical Pathology, 2000
- ERBB2 oncogene in human breast cancer and its clinical significanceEuropean Journal Of Cancer, 1998
- The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactionsFEBS Letters, 1997
- HER‐2/ neu Signal Transduction in Human Breast and Ovarian CancerThe International Journal of Cell Cloning, 1997
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.Proceedings of the National Academy of Sciences, 1992
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12–21.32Genomics, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987